Experienced in Restrictive Cardiomyopathy (RCM)

Mariana Brandao

Rue Meylemeersch 90, 
Brussels, BRU, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Restrictive Cardiomyopathy (RCM)
Rue Meylemeersch 90, 
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Mariana Brandao practices in Brussels, Belgium. Ms. Brandao is rated as an Experienced expert by MediFind in the treatment of Restrictive Cardiomyopathy (RCM). Her top areas of expertise are Breast Cancer, Tangier Disease, Lung Cancer, Mastectomy, and Percutaneous Coronary Intervention (PCI).

Her clinical research consists of co-authoring 105 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Restrictive Cardiomyopathy (RCM).

Gender
Female

Locations

Rue Meylemeersch 90, Brussels, BRU 1070, Belgium
Other Locations
Anderlecht, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 1/2 Modular Dose Escalation With Cohort Expansion of CP-506 (HAP) in Patients With Solid Tumor Types With High Incidence of HRD/FAD in Monotherapy or With Carboplatin or Patients With Solid Tumour and OPD Receiving ICI
Phase 1/2 Modular Dose Escalation With Cohort Expansion of CP-506 (HAP) in Patients With Solid Tumor Types With High Incidence of HRD/FAD in Monotherapy or With Carboplatin or Patients With Solid Tumour and OPD Receiving ICI
Enrollment Status: Recruiting
Publish Date: October 07, 2025
Intervention Type: Drug
Study Drugs: CP-506, Carboplatin, Immune Checkpoint Inhibitor
Study Phase: Phase 1/Phase 2

105 Total Publications

Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Brandao's expertise for a condition
ConditionClose
      View All 37 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile